Constitutive activation of MiT/TFE transcription factors, including TFEB, is identified to drive metabolic reprogramming in pancreatic cancer, and upregulation of TFEB can lead to tumorigenesis of renal cell carcinomas.20, 231. Here, TFEB is linked to renal cell carcinoma.